vs
Side-by-side financial comparison of PROCEPT BioRobotics Corp (PRCT) and P10, Inc. (PX). Click either name above to swap in a different company.
P10, Inc. is the larger business by last-quarter revenue ($81.0M vs $76.4M, roughly 1.1× PROCEPT BioRobotics Corp). P10, Inc. runs the higher net margin — 11.7% vs -39.1%, a 50.7% gap on every dollar of revenue. On growth, PROCEPT BioRobotics Corp posted the faster year-over-year revenue change (11.9% vs -4.7%). P10, Inc. produced more free cash flow last quarter ($18.1M vs $-12.2M). Over the past eight quarters, PROCEPT BioRobotics Corp's revenue compounded faster (31.0% CAGR vs 10.7%).
PROCEPT BioRobotics Corp is a medical tech firm developing and commercializing robotic surgical solutions for urological care. Its flagship AquaBeam system provides image-guided minimally invasive therapy for benign prostatic hyperplasia, serving providers and patients across North America, Europe and global markets.
P10, Inc. is a global alternative investment management firm that offers a diversified portfolio of investment solutions spanning private equity, private credit, real assets and venture capital. It primarily caters to institutional clients including pension funds, endowments, foundations, and high-net-worth individuals across North America, Europe, and Asia Pacific.
PRCT vs PX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $76.4M | $81.0M |
| Net Profit | $-29.8M | $9.5M |
| Gross Margin | 60.6% | — |
| Operating Margin | -40.6% | 31.9% |
| Net Margin | -39.1% | 11.7% |
| Revenue YoY | 11.9% | -4.7% |
| Net Profit YoY | -58.3% | 79.0% |
| EPS (diluted) | $-0.54 | $0.08 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $76.4M | $81.0M | ||
| Q3 25 | $83.3M | $75.9M | ||
| Q2 25 | $79.2M | $72.7M | ||
| Q1 25 | $69.2M | $67.7M | ||
| Q4 24 | $68.2M | $85.0M | ||
| Q3 24 | $58.4M | $74.2M | ||
| Q2 24 | $53.4M | $71.1M | ||
| Q1 24 | $44.5M | $66.1M |
| Q4 25 | $-29.8M | $9.5M | ||
| Q3 25 | $-21.4M | $2.1M | ||
| Q2 25 | $-19.6M | $3.4M | ||
| Q1 25 | $-24.7M | $4.5M | ||
| Q4 24 | $-18.9M | $5.3M | ||
| Q3 24 | $-21.0M | $1.4M | ||
| Q2 24 | $-25.6M | $7.0M | ||
| Q1 24 | $-26.0M | $5.0M |
| Q4 25 | 60.6% | — | ||
| Q3 25 | 64.8% | — | ||
| Q2 25 | 65.4% | — | ||
| Q1 25 | 63.9% | — | ||
| Q4 24 | 64.0% | — | ||
| Q3 24 | 63.2% | — | ||
| Q2 24 | 59.0% | — | ||
| Q1 24 | 56.2% | — |
| Q4 25 | -40.6% | 31.9% | ||
| Q3 25 | -27.8% | 14.1% | ||
| Q2 25 | -28.0% | 24.4% | ||
| Q1 25 | -39.7% | 16.6% | ||
| Q4 24 | -28.9% | 26.9% | ||
| Q3 24 | -38.4% | 11.9% | ||
| Q2 24 | -50.3% | 23.7% | ||
| Q1 24 | -62.1% | 18.3% |
| Q4 25 | -39.1% | 11.7% | ||
| Q3 25 | -25.7% | 2.8% | ||
| Q2 25 | -24.7% | 4.7% | ||
| Q1 25 | -35.8% | 6.7% | ||
| Q4 24 | -27.6% | 6.2% | ||
| Q3 24 | -35.9% | 1.9% | ||
| Q2 24 | -48.0% | 9.8% | ||
| Q1 24 | -58.3% | 7.6% |
| Q4 25 | $-0.54 | $0.08 | ||
| Q3 25 | $-0.38 | $0.02 | ||
| Q2 25 | $-0.35 | $0.03 | ||
| Q1 25 | $-0.45 | $0.04 | ||
| Q4 24 | $-0.34 | $0.05 | ||
| Q3 24 | $-0.40 | $0.01 | ||
| Q2 24 | $-0.50 | $0.06 | ||
| Q1 24 | $-0.51 | $0.04 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $286.5M | $28.2M |
| Total DebtLower is stronger | $51.6M | $373.2M |
| Stockholders' EquityBook value | $365.9M | $403.5M |
| Total Assets | $508.1M | $928.3M |
| Debt / EquityLower = less leverage | 0.14× | 0.93× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $286.5M | $28.2M | ||
| Q3 25 | $294.3M | $40.0M | ||
| Q2 25 | $302.7M | $33.4M | ||
| Q1 25 | $316.2M | $74.4M | ||
| Q4 24 | $333.7M | $67.5M | ||
| Q3 24 | $196.8M | $61.5M | ||
| Q2 24 | $214.1M | $31.2M | ||
| Q1 24 | $225.6M | $29.0M |
| Q4 25 | $51.6M | $373.2M | ||
| Q3 25 | $51.6M | $393.4M | ||
| Q2 25 | $51.5M | $373.0M | ||
| Q1 25 | $51.5M | $357.2M | ||
| Q4 24 | $51.5M | $319.8M | ||
| Q3 24 | $51.4M | $319.4M | ||
| Q2 24 | $51.4M | $300.6M | ||
| Q1 24 | $51.4M | $314.0M |
| Q4 25 | $365.9M | $403.5M | ||
| Q3 25 | $380.3M | $396.8M | ||
| Q2 25 | $385.8M | $388.9M | ||
| Q1 25 | $389.2M | $374.3M | ||
| Q4 24 | $402.2M | $386.9M | ||
| Q3 24 | $241.2M | $394.1M | ||
| Q2 24 | $251.8M | $396.9M | ||
| Q1 24 | $264.0M | $400.1M |
| Q4 25 | $508.1M | $928.3M | ||
| Q3 25 | $511.5M | $936.0M | ||
| Q2 25 | $513.1M | $932.2M | ||
| Q1 25 | $519.4M | $877.4M | ||
| Q4 24 | $534.0M | $869.3M | ||
| Q3 24 | $374.1M | $857.0M | ||
| Q2 24 | $374.4M | $823.2M | ||
| Q1 24 | $382.9M | $832.8M |
| Q4 25 | 0.14× | 0.93× | ||
| Q3 25 | 0.14× | 0.99× | ||
| Q2 25 | 0.13× | 0.96× | ||
| Q1 25 | 0.13× | 0.95× | ||
| Q4 24 | 0.13× | 0.83× | ||
| Q3 24 | 0.21× | 0.81× | ||
| Q2 24 | 0.20× | 0.76× | ||
| Q1 24 | 0.19× | 0.78× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-10.3M | $23.0M |
| Free Cash FlowOCF − Capex | $-12.2M | $18.1M |
| FCF MarginFCF / Revenue | -15.9% | 22.3% |
| Capex IntensityCapex / Revenue | 2.4% | 6.0% |
| Cash ConversionOCF / Net Profit | — | 2.43× |
| TTM Free Cash FlowTrailing 4 quarters | $-58.3M | $14.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-10.3M | $23.0M | ||
| Q3 25 | $-6.6M | $-8.6M | ||
| Q2 25 | $-15.0M | $13.4M | ||
| Q1 25 | $-17.0M | $-4.7M | ||
| Q4 24 | $-32.4M | $101.0M | ||
| Q3 24 | $-18.8M | $27.5M | ||
| Q2 24 | $-15.7M | $34.8M | ||
| Q1 24 | $-32.3M | $11.0M |
| Q4 25 | $-12.2M | $18.1M | ||
| Q3 25 | $-9.5M | $-9.5M | ||
| Q2 25 | $-17.8M | $11.6M | ||
| Q1 25 | $-18.8M | $-6.0M | ||
| Q4 24 | $-33.6M | $96.6M | ||
| Q3 24 | $-19.0M | $25.2M | ||
| Q2 24 | $-16.8M | $33.9M | ||
| Q1 24 | $-34.2M | $10.7M |
| Q4 25 | -15.9% | 22.3% | ||
| Q3 25 | -11.4% | -12.6% | ||
| Q2 25 | -22.5% | 15.9% | ||
| Q1 25 | -27.2% | -8.9% | ||
| Q4 24 | -49.2% | 113.6% | ||
| Q3 24 | -32.6% | 34.0% | ||
| Q2 24 | -31.4% | 47.7% | ||
| Q1 24 | -76.9% | 16.2% |
| Q4 25 | 2.4% | 6.0% | ||
| Q3 25 | 3.4% | 1.2% | ||
| Q2 25 | 3.5% | 2.5% | ||
| Q1 25 | 2.7% | 1.9% | ||
| Q4 24 | 1.7% | 5.2% | ||
| Q3 24 | 0.4% | 3.0% | ||
| Q2 24 | 2.0% | 1.3% | ||
| Q1 24 | 4.4% | 0.4% |
| Q4 25 | — | 2.43× | ||
| Q3 25 | — | -4.01× | ||
| Q2 25 | — | 3.96× | ||
| Q1 25 | — | -1.05× | ||
| Q4 24 | — | 19.12× | ||
| Q3 24 | — | 19.54× | ||
| Q2 24 | — | 4.98× | ||
| Q1 24 | — | 2.18× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PRCT
| Hand Pieces And Other Consumables | $34.1M | 45% |
| System Sales And Rentals | $27.5M | 36% |
| Other | $9.8M | 13% |
| Service Revenue | $5.0M | 7% |
PX
| Management Fees | $78.1M | 96% |
| Advisory Fees | $1.8M | 2% |
